Back to search

France· FR:62883639

RILMENIDINE EVOLUGEN 1 mg, comprimé

A medicinal product containing dihydrogénophosphate de rilménidine, registered in France by EVOLUPHARM, on the national reimbursement list.

Reimbursed in France (Assurance maladie)

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedRILMENIDINE EVOLUGEN 1 mg, compriméATC—REGISTER NO.FR:62883639PACKS LISTED2CHECKEDSeptember 12, 2026

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
DIHYDROGÉNOPHOSPHATE DE RILMÉNIDINE
Manufacturer
EVOLUPHARM
Country
France (FR)
ATC code
—
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 2

2 priced
  • cip13
    3400949933631
    plaquette(s) thermoformée(s) aluminium de 30 comprimé(s)
    EUR 4.65
  • cip13
    3400949933921
    plaquette(s) thermoformée(s) aluminium de 90 comprimé(s)
    EUR 13.08

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Dihydrogénophosphate de rilménidine in 3 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All dihydrogénophosphate de rilménidine products

Authorised across Europe · EMA

The same active substance is authorised in 12 EEA countries. Names it is sold under:

  • Austria · Iterium, Rilmenidin Grindeks
  • Bulgaria · Рилменидин Гриндекс, Рилменикс
  • Czechia · Rilmenidin Teva, Rilmenidine Grindeks
  • Estonia · Rilmenidine Grindeks
  • Hungary · Hyperlex, Rilmenidin Teva
  • Lithuania · Rilmenidine Grindeks, Rilmenidine Teva
  • Luxembourg · Hyperium
  • Latvia · Rilmenidine Grindeks, Rilmenidine Teva
  • Poland · Rilmenidine Grindeks, Tenaxum
  • Portugal · Hyperium, Rilmenidina Grindeks
  • Romania · Rilmenidină Grindeks, Taruza
  • Slovakia · Rilmenidin Teva, Rilmenidine Grindeks

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c4d4f1a9-cea4-4f89-b52a-6c9399ec8d90
GET /v1/drugs/c4d4f1a9-cea4-4f89-b52a-6c9399ec8d90?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "62883639",
  "date_amm": "2010-12-28",
  "type_amm": "Procédure nationale",
  "numero_ue": null,
  "substance": "DIHYDROGÉNOPHOSPHATE DE RILMÉNIDINE",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "comprimé",
  "voies_administration": "orale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about dihydrogénophosphate de rilménidine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.